LY2090314 |
LY2090314 : Inhibitor of GSK3A, GSK3B
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| GSK3A |
| |
| GSK3B |
|
|
Inhibitor
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Screened against a panel of diverse Kinases:
Kinase IC50
GSK-3β 0.0011
Cdk4 1.8
Cdk2 2.8
PKCβII 0.42 ...
Potency Cellular
In Vitro
GSK3A
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm049768a
GSK3B
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm049768a
In Vivo Validations
Rat
Dose: 5 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
0.358 h
Systemic clearance:
3450 mL/h/Kg
Cmax:
1680 ng/mL
Tmax:
0.5 h
Area Under the Curve::
1260 ng*h/mL
Volume of Distribution at Steady-State:
1189 mL/Kg
DOI Reference: 10.1124/dmd.112.048488
Dog
Dose: 5 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
0.662 ± 0.145 h
Systemic clearance:
1673 ± 540 mL/h/Kg
Cmax:
5090 ± 2709 ng/mL
Tmax:
0.5 ± 0.0 h
Area Under the Curve::
3227 ± 1060 ng*h/mL
Volume of Distribution at Steady-State:
915 ± 415 mL/Kg
DOI Reference: 10.1124/dmd.112.048488
Chemical Information
| Molecular Formula | C28H25FN6O3 |
| SMILEs | O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2 |
| InChI | InChI=1S/C28H25FN6O3/c29-18-12-17-15-34(28(38)32-7-3-1-4-8-32)11-10-33-16-20(19(13-18)25(17)33)23-24(27(37)31-26(23)36)21-14-30-22-6-2-5-9-35(21)22/h2,5-6,9,12-14,16H,1,3-4,7-8,10-11,15H2,(H,31,36,37) |
| Molecular weight | 512.20 Da |
| AlogP | 3.4168 |
| HBond acceptors | 9 |
| HBond donors | 1 |
| Atoms | 63 |